Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,068
datasets available to search
ShareScore release 0.9.0
Dataset results
1,068 results for “PD-1”
Side Effects of Anti-PD-(L)-1 and Anti CTLA-A4 in the Non Small Cells Lung Cancer
ClinicalTrials.gov study NCT03125603. IPD Sharing: NO. Countries: 1. Publications: 7.
Nab-paclitaxel Plus PD-1 Inhibitor Versus Nab-paclitaxel As Second-line Treatment in Advanced Gastric Cancer
ClinicalTrials.gov study NCT04294784. IPD Sharing: NO. Countries: 1. Publications: 1.
PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03774732. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and PCSK9 Inhibitor for pMMR/MSS Locally Advanced Mid-low Rectal Cancer
ClinicalTrials.gov study NCT06304987. IPD Sharing: NO. Countries: 1. Publications: 4.
Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for pMMR/MSS Locally Advanced Mid-low Rectal Cancer
ClinicalTrials.gov study NCT06056804. IPD Sharing: NO. Countries: 1. Publications: 4.
Synergistic Effects of PD-1 Antibody and Chemotherapy/Targeted Therapy Followed by Surgery-centric Local Treatment in Patients With Limited-metastatic Gastric Cancer
ClinicalTrials.gov study NCT06468280. IPD Sharing: NO. Countries: 1. Publications: 1.
PD-1 Antibody Combined Neoadjuvant Chemotherapy for Ovarian Cancer
ClinicalTrials.gov study NCT04815408. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Study of PD-1 Inhibitor in Combination With Gemcitabine/Cisplatin for Advancer BTCs
ClinicalTrials.gov study NCT03311789. IPD Sharing: NO. Countries: 1. Publications: 1.
Neoadjuvant PD-1 Inhibitor Dostarlimab (TSR-042) vs. Combination of Tim-3 Inhibitor Cobolimab (TSR-022) and PD-1 Inhibitor Dostarlimab (TSR-042) in Melanoma
ClinicalTrials.gov study NCT04139902. IPD Sharing: NO. Countries: 1. Publications: 1.
First-in-human Study of IO-108 as Single Agent and in Combination With a PD-1 Immune Check Point Inhibitor in Patients With Advanced Solid Tumors
ClinicalTrials.gov study NCT05054348. IPD Sharing: NO. Countries: 1. Publications: 1.
Regorafenib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Patients With Advanced Colorectal Cancer
ClinicalTrials.gov study NCT04771715. IPD Sharing: NO. Countries: 1. Publications: 1.
HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT
ClinicalTrials.gov study NCT05166239. IPD Sharing: NO. Countries: 1. Publications: 22.
Study of PD-1 Inhibitor Combination With Autologous Cell Immunotherapy in the Metastatic Renal Cell Carcinoma
ClinicalTrials.gov study NCT03987698. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase 1 Study of HLX10, a Monoclonal Antibody Targeting Programmed Death-1 (PD-1) in Patients With Advanced Solid Tumors
ClinicalTrials.gov study NCT03468751. IPD Sharing: NO. Countries: 1. Publications: 1.
PD-1 Inhibitor INCMGA00012 as Consolidation Therapy After Definitive Concurrent Chemoradiotherapy
ClinicalTrials.gov study NCT04494009. IPD Sharing: NO. Countries: 1. Publications: 2.
Gecacitinib Combined With Donafenib and PD-1 Inhibitor as Immune Rechallenge Therapy for Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT07157306. IPD Sharing: NO. Countries: 1. Publications: 2.
Neoadjuvant PD-1 Inhibitor (Sintilimab), Anlotinib Combined With Chemotherapy in Resectable Stage IIA-IIIB NSCLC
ClinicalTrials.gov study NCT05400070. IPD Sharing: YES. Countries: 1. Publications: 1.
PD-1 Antibody SHR-1210 Combined With Apatinib of First-line Treatment of Advanced Acral Melanoma
ClinicalTrials.gov study NCT03955354. IPD Sharing: YES. Countries: 1. Publications: 2.
ALPN-202 With PD-1 Inhibition in Advanced Malignancies
ClinicalTrials.gov study NCT04920383. IPD Sharing: Not stated. Countries: 1. Publications: 2.
PD-1 Knockout Engineered T Cells for Advanced Esophageal Cancer
ClinicalTrials.gov study NCT03081715. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.